
--- Page 1 ---
FINAL DIAGNOSIS: Part 1: Lymph nODe, Right AxillA #1 SentineL, biOpsy -- A.: One (1) Lymph nODe POsiTIVe fOr metAstaTIC CArcinomA (1/1). B.  MEtastatic TumOr mEasureS 0.5 Cm. PARt 2: Lymph nODE, RIgHT AXILLA #2 SEntineL, BiOPSY - B METASTATIC FOCUS MEASURES 1.1 CM. C. EXTRACAPSULAR EXTENSION IS IDENTIFIED. PART 3: BREAST, RIGHJ, TOTaL MASteCTOMY - A MOLTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA WITH APOCRINE FEATURES, NOTTINGHAM SCORE 8/9 (TuBuLeS - 2, nuCLEAr GraDe -- 3, MITOSES -3). B. THE LARGER iNVASIVE TUMOR MEASURES 2.4 CM, AND iS LOCATED AT 9:00 O'CLOCK POSITION. C. The Smaller invasive TumOr mEasures 1.1 Cm, And LOcAted at 12 O'clOck pOsitIOn. D. DUCTAL CARCINOMA IN SITU (DCIS), NUCLEAR GRADE 3, APOCRINE AND SOLID TYPES WITH COMEDO NECROSIS. E. DUCTAL CARCINOMA IN SITU CONSTITUTES 20% OF THE TOTAL TUMOR MASS AND iS PRESENT ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT (UPPER OUTER QUADRANT). F. LYMPHOVASCULAR INVASION IS IDENTIFIED. G. ALL SURGICAL MARGINS OF RESECTION ARE FREE OF TUMOR. H.  Nipple is free of tumOr. I. SKiN IS NEGATIVE fOR TUMOR. J.  MICROCALCIFICATIONS ARE PRESENT IN ASSOCIATION WITH DCIS AND INVASIVE CARCINOMA. K. NON-NEOPLASTIC BREAST PARENCHYMA WITH FIBROCYSTIC CHANGES. L. ER POSiTIVE, PR POSITIVE, HER-2/NEU POSITIVE 3t Part 4: Lymph nodes, right axiLlary, Dissection -  One (1) Of Seventeen Lymph nOde pOsitive fOr metastatiC Carcinoma (1/17). A. B. focus Of metastatic Carcinoma measures 1.3 Cm. EXTRACAPSULAR EXTENSION IS iDENTIFiED. 1cs-0-3 Laoe oinupsis: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST Cavcinom nfi/truh'ug ductd,nos 8500f3 LATErALITy: PROCEDUrE: Right Sin:bresf,Nos c50.9 3|r3/1 p LOCAtION: Modified radical mastectomy Upper outer quadrant SIZE OF TUMOR: Lower inner quadrant MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI:  Maximum dimension invasive component: 2.4 cm TUMOR AGGREGATE SIZE: Yes TUMOR TYPE (invasive component): Sum of the sizes of multiple invasive tumors: 3.5 cm NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS Nuclear grade: 3 Tubule formation: 2 UUID: B5ESA3B8-108E-47D3-99DA-EC7A64B5FA9C Mitotic activity score: 3 TCGA-BH-A0B7-01A-PR Redacted Total Nottingham score: 8 ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 3 Yes DERMAL LYMPHATIC INVASION: No CALCIFICATION: Yes, malignant zones Tumor type, in situ: Solid, Apocrine, DCIS admixed and outside of invasive carcinoma component, Ductal. SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:E carcinoma in situ, multifocal, Percent of tumor occupied by in situ component: 20 %. SURG MARGINS iNVOLVED BY IN SITU COMPONENT: No Criter PAgEt'S DISEASE OF nIPpLE: No LymPh nODeS POSITIVE: No LYMPH NODES EXAMINED: 3 METHOD(S) OF LyMPH NODE EXAMInATION: 19 SENTINEL NODE METASTASIS: H/E stain 3/13/11 ONLY KERATIN POSITIVE CELLS ARE PRESENT: Yes SIZE OF NODAL METASTASES: No LYMPH nODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION: Diameter of largest lymph node metastasis: 1.3 mm METASTASES TO IPSILATERAL INTERNAL MAMMARY LYMPH NODE (IF APPLiCABLE): Yes SKIN INVOLVED (ULCERATION): No NON-NEOPLASTIC BREAST TISSUE: FCD No t Stage, patholOgIC: N Stage, patholOgiC: pT2 m Stage, Pathologic: pN1a RAAV